These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 32661114)
1. SOX9 Is Essential for Triple-Negative Breast Cancer Cell Survival and Metastasis. Ma Y; Shepherd J; Zhao D; Bollu LR; Tahaney WM; Hill J; Zhang Y; Mazumdar A; Brown PH Mol Cancer Res; 2020 Dec; 18(12):1825-1838. PubMed ID: 32661114 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of ERRα suppresses epithelial mesenchymal transition of triple negative breast cancer cells by directly targeting fibronectin. Wu YM; Chen ZJ; Liu H; Wei WD; Lu LL; Yang XL; Liang WT; Liu T; Liu HL; Du J; Wang HS Oncotarget; 2015 Sep; 6(28):25588-601. PubMed ID: 26160845 [TBL] [Abstract][Full Text] [Related]
3. Differential expression of epithelial–mesenchymal transition and stem cell markers in intrinsic subtypes of breast cancer. Pomp V; Leo C; Mauracher A; Korol D; Guo W; Varga Z Breast Cancer Res Treat; 2015 Nov; 154(1):45-55. PubMed ID: 26467042 [TBL] [Abstract][Full Text] [Related]
4. LncRNA SOX9-AS1 triggers a transcriptional program involved in lipid metabolic reprogramming, cell migration and invasion in triple-negative breast cancer. Cisneros-Villanueva M; Fonseca-Montaño MA; Ríos-Romero M; López-Camarillo C; Jiménez-Morales S; Langley E; Rosette-Rueda AS; Cedro-Tanda A; Hernández-Sotelo D; Hidalgo-Miranda A Sci Rep; 2024 Jan; 14(1):1483. PubMed ID: 38233470 [TBL] [Abstract][Full Text] [Related]
6. NOTCH4 maintains quiescent mesenchymal-like breast cancer stem cells via transcriptionally activating SLUG and GAS1 in triple-negative breast cancer. Zhou L; Wang D; Sheng D; Xu J; Chen W; Qin Y; Du R; Yang X; He X; Xie N; Liu S; Zhang L Theranostics; 2020; 10(5):2405-2421. PubMed ID: 32104513 [No Abstract] [Full Text] [Related]
7. STAT3 Targets Ma JH; Qi J; Lin SQ; Zhang CY; Liu FY; Xie WD; Li X Mol Cancer Res; 2019 Nov; 17(11):2184-2195. PubMed ID: 31427441 [TBL] [Abstract][Full Text] [Related]
8. SALL4 promotes tumor progression in breast cancer by targeting EMT. Chen T; Tsang JYS; Su XC; Li P; Sun WQ; Wong ILK; Choy KY; Yang Q; Tse GMK; Chan TH; Chow LMC Mol Carcinog; 2020 Oct; 59(10):1209-1226. PubMed ID: 32835442 [TBL] [Abstract][Full Text] [Related]
9. Integration of whole-genome sequencing and functional screening identifies a prognostic signature for lung metastasis in triple-negative breast cancer. Xie G; Yang H; Ma D; Sun Y; Chen H; Hu X; Jiang YZ; Shao ZM Int J Cancer; 2019 Nov; 145(10):2850-2860. PubMed ID: 30977117 [TBL] [Abstract][Full Text] [Related]
10. microRNA-200c/141 upregulates SerpinB2 to promote breast cancer cell metastasis and reduce patient survival. Jin T; Suk Kim H; Ki Choi S; Hye Hwang E; Woo J; Suk Ryu H; Kim K; Moon A; Kyung Moon W Oncotarget; 2017 May; 8(20):32769-32782. PubMed ID: 28427146 [TBL] [Abstract][Full Text] [Related]
11. Tamoxifen reverses epithelial-mesenchymal transition by demethylating miR-200c in triple-negative breast cancer cells. Wang Q; Cheng Y; Wang Y; Fan Y; Li C; Zhang Y; Wang Y; Dong Q; Ma Y; Teng YE; Qu X; Liu Y BMC Cancer; 2017 Jul; 17(1):492. PubMed ID: 28724364 [TBL] [Abstract][Full Text] [Related]
12. CD155 contributes to the mesenchymal phenotype of triple-negative breast cancer. Zheng Q; Gao J; Yin P; Wang W; Wang B; Li Y; Zhao C Cancer Sci; 2020 Feb; 111(2):383-394. PubMed ID: 31830330 [TBL] [Abstract][Full Text] [Related]
13. Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling. Jiang HL; Sun HF; Gao SP; Li LD; Hu X; Wu J; Jin W Oncotarget; 2015 Jun; 6(18):16352-65. PubMed ID: 25970785 [TBL] [Abstract][Full Text] [Related]
14. RNA-binding protein MSI2 isoforms expression and regulation in progression of triple-negative breast cancer. Li M; Li AQ; Zhou SL; Lv H; Wei P; Yang WT J Exp Clin Cancer Res; 2020 May; 39(1):92. PubMed ID: 32448269 [TBL] [Abstract][Full Text] [Related]
15. A novel long non-coding RNA linc-ZNF469-3 promotes lung metastasis through miR-574-5p-ZEB1 axis in triple negative breast cancer. Wang PS; Chou CH; Lin CH; Yao YC; Cheng HC; Li HY; Chuang YC; Yang CN; Ger LP; Chen YC; Lin FC; Shen TL; Hsiao M; Lu PJ Oncogene; 2018 Aug; 37(34):4662-4678. PubMed ID: 29755127 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer. Granados-Principal S; Liu Y; Guevara ML; Blanco E; Choi DS; Qian W; Patel T; Rodriguez AA; Cusimano J; Weiss HL; Zhao H; Landis MD; Dave B; Gross SS; Chang JC Breast Cancer Res; 2015 Feb; 17(1):25. PubMed ID: 25849745 [TBL] [Abstract][Full Text] [Related]
17. An exploratory study for tuft cells in the breast and their relevance in triple-negative breast cancer: the possible relationship of SOX9. Yamada Y; Simon R; Iwane K; Nakanishi Y; Takeuchi Y; Yoshizawa A; Takada M; Toi M; Haga H; Marx A; Sauter G BMC Cancer; 2023 May; 23(1):438. PubMed ID: 37179317 [TBL] [Abstract][Full Text] [Related]
18. TGF-β1-SOX9 axis-inducible COL10A1 promotes invasion and metastasis in gastric cancer via epithelial-to-mesenchymal transition. Li T; Huang H; Shi G; Zhao L; Li T; Zhang Z; Liu R; Hu Y; Liu H; Yu J; Li G Cell Death Dis; 2018 Aug; 9(9):849. PubMed ID: 30154451 [TBL] [Abstract][Full Text] [Related]
19. FOXM1 transcriptionally regulates expression of integrin β1 in triple-negative breast cancer. Hamurcu Z; Kahraman N; Ashour A; Ozpolat B Breast Cancer Res Treat; 2017 Jun; 163(3):485-493. PubMed ID: 28361350 [TBL] [Abstract][Full Text] [Related]
20. RNA binding protein RBMS3 is a common EMT effector that modulates triple-negative breast cancer progression via stabilizing PRRX1 mRNA. Block CJ; Mitchell AV; Wu L; Glassbrook J; Craig D; Chen W; Dyson G; DeGracia D; Polin L; Ratnam M; Gibson H; Wu G Oncogene; 2021 Nov; 40(46):6430-6442. PubMed ID: 34608266 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]